Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ (Tixagevimab/Cilgavimab) During Pregnancy

NCT05847140 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05847140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05847140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Multi-country Cohort Study to Assess the Safety of EVUSHELD™ (Tixagevimab/Cilgavimab) During Pregnancy
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Withdrawn
Start date
June 27, 2022
Completion date
January 31, 2024
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

pregnancy, pregnancy outcome, pregnant women